• https://www.databridgemarketresearch.com/reports/asia-pacific-digital-diabetes-management-market
    https://www.databridgemarketresearch.com/reports/asia-pacific-digital-diabetes-management-market
    Asia-Pacific Digital Diabetes Management Market Report – Industry Trends and Forecast to 2028 | Data Bridge Market Research
    The Asia-Pacific Digital Diabetes Management market was valued at USD 0.00 in 2023 and is expected to reach USD 0.00 by 2030, growing at a CAGR of 0% (2024-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
    0 Comentários 0 Compartilhamentos 665 Visualizações 0 Anterior
  • The #Continuous #Glucose #Monitoring (CGM) #devices #market is expanding rapidly as diabetes becomes more prevalent, sensor technology advances, and demand for real-time glucose monitoring rises. CGM devices continuously monitor blood glucose levels, offering useful information for diabetes management.

    https://www.linkedin.com/pulse/continuous-glucose-monitoring-devices-market-size-analysis-kashid-fkzgc/
    The #Continuous #Glucose #Monitoring (CGM) #devices #market is expanding rapidly as diabetes becomes more prevalent, sensor technology advances, and demand for real-time glucose monitoring rises. CGM devices continuously monitor blood glucose levels, offering useful information for diabetes management. https://www.linkedin.com/pulse/continuous-glucose-monitoring-devices-market-size-analysis-kashid-fkzgc/
    WWW.LINKEDIN.COM
    Continuous Glucose Monitoring Devices Market Size Analysis, Growth Trends & Forecast to 2035
    The Continuous Glucose Monitoring Devices Market is growing rapidly, driven by demand for real-time diabetes management and advanced healthcare technology.
    0 Comentários 0 Compartilhamentos 940 Visualizações 0 Anterior
  • Continuous Glucose Monitoring (CGM) devices are advanced systems that track blood glucose levels in real time, offering a convenient and non-invasive alternative to traditional fingerstick tests. These devices use a small sensor placed under the skin to measure glucose levels continuously, providing valuable insights for diabetes management. CGMs help users detect trends, prevent spikes or drops, and improve overall glucose control.
    https://wemarketresearch.com/reports/continuous-glucose-monitoring-devices-market/1672
    Continuous Glucose Monitoring (CGM) devices are advanced systems that track blood glucose levels in real time, offering a convenient and non-invasive alternative to traditional fingerstick tests. These devices use a small sensor placed under the skin to measure glucose levels continuously, providing valuable insights for diabetes management. CGMs help users detect trends, prevent spikes or drops, and improve overall glucose control. https://wemarketresearch.com/reports/continuous-glucose-monitoring-devices-market/1672
    WEMARKETRESEARCH.COM
    Continuous Glucose Monitoring Devices Market Report 2025-35
    Continuous Glucose Monitoring Devices market is set to grow from USD 6.1B in 2025 to USD 18.3B by 2035, with a 10.6% CAGR, driven by rising diabetes cases.
    0 Comentários 0 Compartilhamentos 740 Visualizações 0 Anterior
  • https://www.maximizemarketresearch.com/market-report/diabetes-management-market/1114/
    https://www.maximizemarketresearch.com/market-report/diabetes-management-market/1114/
    WWW.MAXIMIZEMARKETRESEARCH.COM
    Diabetes Management Market - Global Industry Analysis and Forecast (2024-2030)
    Diabetes Management Market CAGR is expected to be 23.7% and the market size is expected to reach nearly US$ 71.48 Bn. by 2030.
    0 Comentários 0 Compartilhamentos 250 Visualizações 0 Anterior
  • https://www.maximizemarketresearch.com/market-report/diabetes-management-market/1114/
    https://www.maximizemarketresearch.com/market-report/diabetes-management-market/1114/
    WWW.MAXIMIZEMARKETRESEARCH.COM
    Diabetes Management Market - Global Industry Analysis and Forecast (2024-2030)
    Diabetes Management Market CAGR is expected to be 23.7% and the market size is expected to reach nearly US$ 71.48 Bn. by 2030.
    0 Comentários 0 Compartilhamentos 256 Visualizações 0 Anterior
  • https://www.maximizemarketresearch.com/market-report/global-lancets-market/31935/

    The lancets market is expanding as the global demand for diabetes management tools rises. Lancets, essential for blood glucose testing, are becoming more advanced with features that improve comfort and accuracy.


    #HomeHealthcare #MedicalDevices #HealthcareInnovation #DiabetesCare #HealthTech
    https://www.maximizemarketresearch.com/market-report/global-lancets-market/31935/ The lancets market is expanding as the global demand for diabetes management tools rises. Lancets, essential for blood glucose testing, are becoming more advanced with features that improve comfort and accuracy. #HomeHealthcare #MedicalDevices #HealthcareInnovation #DiabetesCare #HealthTech
    WWW.MAXIMIZEMARKETRESEARCH.COM
    Lancets Market - Global Industry Analysis and Forecast (2024-2030)
    Lancets Market size was valued at US$ 1283.27 Mn. in 2023 and it is expected to grow at a CAGR of 12.4% through 2024 to 2030
    0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
  • Dietary Guidelines in Ayurveda for Diabetes Management
    Ayurveda does not treat diabetes solely as a blood sugar issue; it views the disease as a systemic imbalance that involves the whole body. A personalized approach, which includes dietary modifications, herbal remedies, and lifestyle changes, forms the foundation of Ayurvedic treatment for diabetes.
    Read More: https://articlepaid.com/preview/dietary-guidelines-in-ayurveda-for-diabetes-management
    Dietary Guidelines in Ayurveda for Diabetes Management Ayurveda does not treat diabetes solely as a blood sugar issue; it views the disease as a systemic imbalance that involves the whole body. A personalized approach, which includes dietary modifications, herbal remedies, and lifestyle changes, forms the foundation of Ayurvedic treatment for diabetes. Read More: https://articlepaid.com/preview/dietary-guidelines-in-ayurveda-for-diabetes-management
    0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
  • The Benefits of Linahert 5 Tablet: A Key Medication for Type 2 Diabetes Management

    Linahert 5 Tablet, containing the active ingredient Linagliptin, is a widely used medication for managing type 2 diabetes mellitus. It belongs to a class of drugs known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels by increasing insulin production and decreasing the amount of sugar produced by the liver. Linahert 5 Tablet works by prolonging the activity of incretin hormones, which are responsible for stimulating insulin release in response to meals. This helps maintain more stable blood sugar levels throughout the day, particularly after eating, making it an effective treatment option for individuals struggling to control their glucose levels with lifestyle changes alone.

    One of the standout benefits of Linahert 5 is its low risk of hypoglycemia, as it only increases insulin when blood sugar levels are elevated, reducing the risk of dangerously low blood sugar. Additionally, it is weight-neutral, meaning it does not contribute to weight gain, a common concern with many diabetes medications. Linahert 5 is also convenient to use, as it is typically taken once daily, making it easier for patients to adhere to their treatment regimen. When used in combination with a balanced diet and regular exercise, Linahert 5 can significantly improve overall diabetes management, offering patients a safer and more manageable approach to controlling their blood sugar.

    More info : https://hertzpharma.in/linahert.php
    The Benefits of Linahert 5 Tablet: A Key Medication for Type 2 Diabetes Management Linahert 5 Tablet, containing the active ingredient Linagliptin, is a widely used medication for managing type 2 diabetes mellitus. It belongs to a class of drugs known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels by increasing insulin production and decreasing the amount of sugar produced by the liver. Linahert 5 Tablet works by prolonging the activity of incretin hormones, which are responsible for stimulating insulin release in response to meals. This helps maintain more stable blood sugar levels throughout the day, particularly after eating, making it an effective treatment option for individuals struggling to control their glucose levels with lifestyle changes alone. One of the standout benefits of Linahert 5 is its low risk of hypoglycemia, as it only increases insulin when blood sugar levels are elevated, reducing the risk of dangerously low blood sugar. Additionally, it is weight-neutral, meaning it does not contribute to weight gain, a common concern with many diabetes medications. Linahert 5 is also convenient to use, as it is typically taken once daily, making it easier for patients to adhere to their treatment regimen. When used in combination with a balanced diet and regular exercise, Linahert 5 can significantly improve overall diabetes management, offering patients a safer and more manageable approach to controlling their blood sugar. More info : https://hertzpharma.in/linahert.php
    0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
  • BODY IMAGE
    What Are the Risks and Benefits of Weight-Loss Shot?
    Questions, answers, and considerations from two health professionals.
    Reviewed by Vanessa Lancaster

    KEY POINTS-
    “Ozempic face” and digestive and endocrine risks have been reported as possible side effects of taking semaglutide medications.
    Restricting nutritional intake can affect mood and mental health, whether by shot or dieting.
    Doctors report that people who stopped taking semaglutide medications have hunger return to the same, if not a greater, level than before.

    You’re in your doctor’s office when "You need to lose weight" booms through the room. They offer Wegovy or Ozempic as a solution.

    I hear about this happening often. And as an eating and body image specialist, I have some questions. I'm not alone. For example, the topics of Ozempic and Wegovy dominated a recent professionals' consultation group. Many of our patients, family members, and friends have been offered these shots for weight loss, not diabetes. None of us clinicians knew much about these medications. (And we probably should because we are people in the eating and body image field!)

    What is Ozempic? Wegovy?
    What happens if someone stops taking it? Do people have to take the shots forever?
    What are the long-term effects?
    How might taking Ozempic or Wegovy affect mental health? Physical health?
    Are these injections a solution to body-image issues?
    I imagine many people considering Ozempic or Wegovy probably have these questions, too. So I invited my colleague, eating disorders specialist Jessica Johns-Green, LPC, to join me in finding answers to some of those questions.

    1. What are Ozempic and Wegovy?
    Ozempic and Wegovy are both semaglutide medications. Using their brand names, Ozempic was FDA approved in 2017 for type 2 diabetes management and Wegovy in 2021 for weight management. Depending on which, the dosing differs. For readers who like a summary, these semaglutide medications can make you feel full while eating less by jockeying the hormones. For those who want more details, these shots help the pancreas release the right amount of insulin and slow the stomach's natural process. According to the FDA’s report in June 2021, semaglutide drugs mimic a hormone called GLP-1 that stimulates insulin secretion and lowers glucagon released from the liver (FDA, 2021).

    2. What happens if you stop taking it? Do you have to take the shots forever?
    Evidence indicates that the weight generally comes back (Wilding et al., 2022). Reports from doctors’ observations are that people who stopped taking semaglutide medications have hunger return to the same if not a greater, level than before (Lovelace, 2023). This phenomenon mirrors much of what we know about extreme dieting generally–when the body has been deprived, the hunger typically returns with a vengeance (Coutinho, 2018; Siahpush et al., 2015). Increased appetite means the most likely scenario is the lost pounds or kilograms returning. Some semaglutide users gained back more than before (Constantino, 2023).

    So do you have to take the shots forever? Well, from our reading, “It depends.” Evolving research will likely reveal a clearer answer.

    3. What are the long-term effects of being on Ozempic or Wegovy?
    Though much is still unknown, here’s what science says so far:

    Semaglutide medications carry the risk of thyroid cancer in animal trials (National Library of Medicine, 2023).
    In people who have used the drug longer term for diabetes, there may be a risk of kidney disease (Leehey et al., 2021).
    Further, we might not be unreasonable to wonder about the long-term effects on hormone levels and functioning. But it will take some time to gather more information.

    4. How can it affect your physical health? Mental health?
    Physically, users routinely complain of nausea, vomiting, fatigue, racing heart, and changes to bowel movements such as diarrhea or constipation (Wegovy® Side Effects, n.d.). Dehydration has also been reported, which can also put kidneys at risk (Ozempic, n.d.). Another common side effect is something termed “Ozempic face," which is when the face looks aged and sagging. It is not clear what causes this facial change. Some doctors speculate that it may result from rapid fat loss (Cohen, 2023).

    In terms of mental health, much remains to be seen. Do you know anyone on it? Starting with the Minnesota Starvation Experiment nearly 80 years ago, science has repeatedly shown that undereating can result in symptoms such as increased anxiety, obsessiveness, social isolation, high to low moods, irritability, euphoria, etc. (Keys et al., 1950). Are you (or they) experiencing any of these types of symptoms? For those who started Wegovy or Ozempic for body-image disturbances, are those issues fixed?

    5. Is this a solution for body-image issues?
    For most of us, body image results from many years and layers of conditioned beliefs that play out as we look in the mirror or see ourselves in photos, window reflections, and our minds. Based on other populations that change their bodies to improve how they feel emotionally, it is not likely that these weight-loss medications will offer a permanent solution to poor body image (Lacroix et al., 2022).

    Because semaglutide weight-loss injections are a newer approach, we asked a psychiatric nurse practitioner specializing in eating and body image issues, Esder Shin, for her opinion. She said,

    Ozempic and other weight-loss medications might be a tempting solution for many; however, it is important to understand that these medications may actually exacerbate body image issues and worsen symptoms of disordered eating and gastrointestinal problems. This can cause one to feel even more self-conscious about themselves. I cannot stress enough to my patients how important it is to work on developing a healthy relationship with their bodies where patients can allow themselves to achieve a greater sense of self-confidence and overall well-being.

    Wrapping Up
    At this point, we feel concerned about weight-loss shots potentially triggering or exacerbating eating disorders for those vulnerable. No one can know who is biologically at risk of developing a clinical eating disorder. An imbalance in energy/nutritional intake versus energy output can push the metaphorical “on” button for someone who has it inside of them. We are also aware of various studies supporting that most diets and extreme attempts at weight loss do not result in sustained weight loss (Mann, 2018), meaning the diets fail you and not the other way around. Still, research on these weight-loss injections continues to evolve. So, it seems that it's a “wait and see” for all of us.

    While you sort out how you feel about the potential risks and benefits of using these shots for weight management, speaking to a well-trained therapist in eating, body image issues, and eating disorders could benefit you.

    Please note that nothing in this article constitutes professional advice or therapy.
    BODY IMAGE What Are the Risks and Benefits of Weight-Loss Shot? Questions, answers, and considerations from two health professionals. Reviewed by Vanessa Lancaster KEY POINTS- “Ozempic face” and digestive and endocrine risks have been reported as possible side effects of taking semaglutide medications. Restricting nutritional intake can affect mood and mental health, whether by shot or dieting. Doctors report that people who stopped taking semaglutide medications have hunger return to the same, if not a greater, level than before. You’re in your doctor’s office when "You need to lose weight" booms through the room. They offer Wegovy or Ozempic as a solution. I hear about this happening often. And as an eating and body image specialist, I have some questions. I'm not alone. For example, the topics of Ozempic and Wegovy dominated a recent professionals' consultation group. Many of our patients, family members, and friends have been offered these shots for weight loss, not diabetes. None of us clinicians knew much about these medications. (And we probably should because we are people in the eating and body image field!) What is Ozempic? Wegovy? What happens if someone stops taking it? Do people have to take the shots forever? What are the long-term effects? How might taking Ozempic or Wegovy affect mental health? Physical health? Are these injections a solution to body-image issues? I imagine many people considering Ozempic or Wegovy probably have these questions, too. So I invited my colleague, eating disorders specialist Jessica Johns-Green, LPC, to join me in finding answers to some of those questions. 1. What are Ozempic and Wegovy? Ozempic and Wegovy are both semaglutide medications. Using their brand names, Ozempic was FDA approved in 2017 for type 2 diabetes management and Wegovy in 2021 for weight management. Depending on which, the dosing differs. For readers who like a summary, these semaglutide medications can make you feel full while eating less by jockeying the hormones. For those who want more details, these shots help the pancreas release the right amount of insulin and slow the stomach's natural process. According to the FDA’s report in June 2021, semaglutide drugs mimic a hormone called GLP-1 that stimulates insulin secretion and lowers glucagon released from the liver (FDA, 2021). 2. What happens if you stop taking it? Do you have to take the shots forever? Evidence indicates that the weight generally comes back (Wilding et al., 2022). Reports from doctors’ observations are that people who stopped taking semaglutide medications have hunger return to the same if not a greater, level than before (Lovelace, 2023). This phenomenon mirrors much of what we know about extreme dieting generally–when the body has been deprived, the hunger typically returns with a vengeance (Coutinho, 2018; Siahpush et al., 2015). Increased appetite means the most likely scenario is the lost pounds or kilograms returning. Some semaglutide users gained back more than before (Constantino, 2023). So do you have to take the shots forever? Well, from our reading, “It depends.” Evolving research will likely reveal a clearer answer. 3. What are the long-term effects of being on Ozempic or Wegovy? Though much is still unknown, here’s what science says so far: Semaglutide medications carry the risk of thyroid cancer in animal trials (National Library of Medicine, 2023). In people who have used the drug longer term for diabetes, there may be a risk of kidney disease (Leehey et al., 2021). Further, we might not be unreasonable to wonder about the long-term effects on hormone levels and functioning. But it will take some time to gather more information. 4. How can it affect your physical health? Mental health? Physically, users routinely complain of nausea, vomiting, fatigue, racing heart, and changes to bowel movements such as diarrhea or constipation (Wegovy® Side Effects, n.d.). Dehydration has also been reported, which can also put kidneys at risk (Ozempic, n.d.). Another common side effect is something termed “Ozempic face," which is when the face looks aged and sagging. It is not clear what causes this facial change. Some doctors speculate that it may result from rapid fat loss (Cohen, 2023). In terms of mental health, much remains to be seen. Do you know anyone on it? Starting with the Minnesota Starvation Experiment nearly 80 years ago, science has repeatedly shown that undereating can result in symptoms such as increased anxiety, obsessiveness, social isolation, high to low moods, irritability, euphoria, etc. (Keys et al., 1950). Are you (or they) experiencing any of these types of symptoms? For those who started Wegovy or Ozempic for body-image disturbances, are those issues fixed? 5. Is this a solution for body-image issues? For most of us, body image results from many years and layers of conditioned beliefs that play out as we look in the mirror or see ourselves in photos, window reflections, and our minds. Based on other populations that change their bodies to improve how they feel emotionally, it is not likely that these weight-loss medications will offer a permanent solution to poor body image (Lacroix et al., 2022). Because semaglutide weight-loss injections are a newer approach, we asked a psychiatric nurse practitioner specializing in eating and body image issues, Esder Shin, for her opinion. She said, Ozempic and other weight-loss medications might be a tempting solution for many; however, it is important to understand that these medications may actually exacerbate body image issues and worsen symptoms of disordered eating and gastrointestinal problems. This can cause one to feel even more self-conscious about themselves. I cannot stress enough to my patients how important it is to work on developing a healthy relationship with their bodies where patients can allow themselves to achieve a greater sense of self-confidence and overall well-being. Wrapping Up At this point, we feel concerned about weight-loss shots potentially triggering or exacerbating eating disorders for those vulnerable. No one can know who is biologically at risk of developing a clinical eating disorder. An imbalance in energy/nutritional intake versus energy output can push the metaphorical “on” button for someone who has it inside of them. We are also aware of various studies supporting that most diets and extreme attempts at weight loss do not result in sustained weight loss (Mann, 2018), meaning the diets fail you and not the other way around. Still, research on these weight-loss injections continues to evolve. So, it seems that it's a “wait and see” for all of us. While you sort out how you feel about the potential risks and benefits of using these shots for weight management, speaking to a well-trained therapist in eating, body image issues, and eating disorders could benefit you. Please note that nothing in this article constitutes professional advice or therapy.
    0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
  • ADDICTION-
    This Underutilized Addiction Medication Can Save Lives.
    Restrictions on buprenorphine have been removed, but broader access is needed.
    Reviewed by Tyler Woods

    KEY POINTS-
    Buprenorphine is a safe, evidence-based medication for opioid use disorder that can control drug cravings and prevent overdose deaths.
    Despite its safety profile, buprenorphine is under-prescribed, due to a lack of medical provider training, as well as stigma.
    The federal government recently lifted a regulatory burden on buprenorphine, but patients still need to advocate for access the medication.
    More than 100,000 people are dying of drug overdoses each year in America, driven chiefly by opioids.

    Medications can prevent opioid overdoses by blocking the effects of deadly drugs while also controlling cravings to use those drugs. Yet, they are vastly underutilized. Less than one-third of people in need of medications for opioid use disorder (OUD) receive them.

    One of the evidence-based medications for OUD is buprenorphine. Approved by the FDA in 2002, until recently it could only be prescribed by providers who took a special course and applied for a waiver, known as an X-waiver. At the end of last year, the federal government lifted this regulatory burden. It remains to be seen whether this change will save lives.

    The two other FDA-approved medications for OUD, methadone and naltrexone, have more limited use. Methadone cannot be written as a prescription for OUD but rather must be dispensed by a federally certified clinic. Naltrexone is available as a prescription but is less effective than buprenorphine or methadone.

    People in need of OUD treatment should seek treatment settings that offer medications, in particular, buprenorphine.

    How Does Buprenorphine Work?
    Buprenorphine is a partial opioid. It attaches to opioid receptors in the brain, just as heroin, fentanyl, and other full opioids do—but relative to other opioids, buprenorphine activates those receptors weakly. Think of a lackluster opening act when you go to see a show—it’s enough to keep you in your seat, but it’s not the main performance.

    Buprenorphine can control cravings to use other opioids, but as long it is dosed properly, it does not cause intoxication or suppress breathing, which is the mechanism of opioid overdose. Now, imagine if that bland opening act refused to leave the stage, keeping the main act stuck behind the curtain. That is how buprenorphine prevents overdoses: it clings more tightly to the opioid receptors than full opioids do. When people use other opioids while on buprenorphine, they do not get high or stop breathing.

    Why Is Buprenorphine Underutilized?
    For most of history, addiction was stigmatized as a moral failing. It was not until 1997 that the National Institute on Drug Abuse introduced the concept of addiction as a brain disease, and not until 2012 that a landmark report connected the growing issue of untreated addiction to a dearth of medical training. Even today, many drug treatment programs consider recovery to mean abstention from use of all opioids; they do not consider a person who is taking buprenorphine to have achieved recovery.

    The recently revoked X-waiver also posed a barrier; fewer than 100,000 clinicians in the country had one as of January 2021. Given the irony that no such waiver was required to prescribe the oxycodone, Percocet, and other full opioids that delivered us an epidemic in the first place, the X-ing of the X-waiver is a cause for celebration.

    Yet it is premature to declare victory in the struggle for broad access to buprenorphine. One study that assisted clinicians in obtaining an X-waiver, including providing the requisite training course, found that the majority did not use the waiver. Medical training curricula have a gaping hole when it comes to addiction, one which a single course cannot fill.

    Starting buprenorphine can be tricky. If initiated too soon after the last use of a full opioid, it will displace that full opioid from its receptor in the brain, precipitating a sickness known as withdrawal. Sometimes described as “leaking from every orifice,” withdrawal involves watery eyes, a runny nose, vomiting, diarrhea, and more. Imagine if the boring opener pushed the headliner off the stage mid-act—the audience would be pretty miserable. On the other hand, if the main act suddenly left mid-performance, the opener could step in to fill the time, cheering everyone up. Similarly, once a person with opioid dependence is already experiencing significant withdrawal, buprenorphine can soothe the symptoms.

    How Can These Barriers Be Overcome?
    With appropriate education, patients can start buprenorphine at home without precipitating withdrawal. Inpatient and residential facilities can observe patients until they have reached the appropriate stage of opioid withdrawal for buprenorphine to alleviate rather than exacerbate their symptoms.

    Many rehab facilities do this already—only to stop buprenorphine once the withdrawal has resolved. They may claim that at this point the patient has completed “detoxification,” or “detox,” but the use of these terms can perpetuate the stigma that a person who uses drugs needs to be “cleaned” in some way. Moreover, addiction is a chronic medical condition that warrants treatment with maintenance medications, just as, for instance, diabetes management may require long-term use of insulin. Limiting the use of medications to the withdrawal phase disregards clinical reality and undermines recovery.

    Rehab facilities bear a special responsibility to not only start buprenorphine but also to link patients to a community prescriber who will continue the medication after discharge. Buprenorphine can control the cravings to use drugs that are triggered by the stressors of returning to the real world after rehab. Moreover, while sequestered at rehab, people lose their tolerance to opioids. With their bodies no longer accustomed to using the amount of street drugs that they used before, they are especially vulnerable to a fatal overdose—which can be prevented with buprenorphine.

    How Can People With OUD Access Buprenorphine Treatment?
    If a patient with OUD is safe in their current home environment, they can start buprenorphine while remaining in the community. You can find outpatient buprenorphine prescribers here.

    If you or your loved one is seeking inpatient or residential treatment for OUD, inquire about each facility’s policy on buprenorphine. This means asking not only whether they provide short-term buprenorphine for withdrawal management (or “detox”) but also whether they support long-term use, including providing a bridge prescription to last until patients establish with an outpatient prescriber.

    By asserting a right to evidence-based treatment, patients and their loved ones can erode the stigma against medications that has clung to the addiction treatment world for far too long.

    ADDICTION- This Underutilized Addiction Medication Can Save Lives. Restrictions on buprenorphine have been removed, but broader access is needed. Reviewed by Tyler Woods KEY POINTS- Buprenorphine is a safe, evidence-based medication for opioid use disorder that can control drug cravings and prevent overdose deaths. Despite its safety profile, buprenorphine is under-prescribed, due to a lack of medical provider training, as well as stigma. The federal government recently lifted a regulatory burden on buprenorphine, but patients still need to advocate for access the medication. More than 100,000 people are dying of drug overdoses each year in America, driven chiefly by opioids. Medications can prevent opioid overdoses by blocking the effects of deadly drugs while also controlling cravings to use those drugs. Yet, they are vastly underutilized. Less than one-third of people in need of medications for opioid use disorder (OUD) receive them. One of the evidence-based medications for OUD is buprenorphine. Approved by the FDA in 2002, until recently it could only be prescribed by providers who took a special course and applied for a waiver, known as an X-waiver. At the end of last year, the federal government lifted this regulatory burden. It remains to be seen whether this change will save lives. The two other FDA-approved medications for OUD, methadone and naltrexone, have more limited use. Methadone cannot be written as a prescription for OUD but rather must be dispensed by a federally certified clinic. Naltrexone is available as a prescription but is less effective than buprenorphine or methadone. People in need of OUD treatment should seek treatment settings that offer medications, in particular, buprenorphine. How Does Buprenorphine Work? Buprenorphine is a partial opioid. It attaches to opioid receptors in the brain, just as heroin, fentanyl, and other full opioids do—but relative to other opioids, buprenorphine activates those receptors weakly. Think of a lackluster opening act when you go to see a show—it’s enough to keep you in your seat, but it’s not the main performance. Buprenorphine can control cravings to use other opioids, but as long it is dosed properly, it does not cause intoxication or suppress breathing, which is the mechanism of opioid overdose. Now, imagine if that bland opening act refused to leave the stage, keeping the main act stuck behind the curtain. That is how buprenorphine prevents overdoses: it clings more tightly to the opioid receptors than full opioids do. When people use other opioids while on buprenorphine, they do not get high or stop breathing. Why Is Buprenorphine Underutilized? For most of history, addiction was stigmatized as a moral failing. It was not until 1997 that the National Institute on Drug Abuse introduced the concept of addiction as a brain disease, and not until 2012 that a landmark report connected the growing issue of untreated addiction to a dearth of medical training. Even today, many drug treatment programs consider recovery to mean abstention from use of all opioids; they do not consider a person who is taking buprenorphine to have achieved recovery. The recently revoked X-waiver also posed a barrier; fewer than 100,000 clinicians in the country had one as of January 2021. Given the irony that no such waiver was required to prescribe the oxycodone, Percocet, and other full opioids that delivered us an epidemic in the first place, the X-ing of the X-waiver is a cause for celebration. Yet it is premature to declare victory in the struggle for broad access to buprenorphine. One study that assisted clinicians in obtaining an X-waiver, including providing the requisite training course, found that the majority did not use the waiver. Medical training curricula have a gaping hole when it comes to addiction, one which a single course cannot fill. Starting buprenorphine can be tricky. If initiated too soon after the last use of a full opioid, it will displace that full opioid from its receptor in the brain, precipitating a sickness known as withdrawal. Sometimes described as “leaking from every orifice,” withdrawal involves watery eyes, a runny nose, vomiting, diarrhea, and more. Imagine if the boring opener pushed the headliner off the stage mid-act—the audience would be pretty miserable. On the other hand, if the main act suddenly left mid-performance, the opener could step in to fill the time, cheering everyone up. Similarly, once a person with opioid dependence is already experiencing significant withdrawal, buprenorphine can soothe the symptoms. How Can These Barriers Be Overcome? With appropriate education, patients can start buprenorphine at home without precipitating withdrawal. Inpatient and residential facilities can observe patients until they have reached the appropriate stage of opioid withdrawal for buprenorphine to alleviate rather than exacerbate their symptoms. Many rehab facilities do this already—only to stop buprenorphine once the withdrawal has resolved. They may claim that at this point the patient has completed “detoxification,” or “detox,” but the use of these terms can perpetuate the stigma that a person who uses drugs needs to be “cleaned” in some way. Moreover, addiction is a chronic medical condition that warrants treatment with maintenance medications, just as, for instance, diabetes management may require long-term use of insulin. Limiting the use of medications to the withdrawal phase disregards clinical reality and undermines recovery. Rehab facilities bear a special responsibility to not only start buprenorphine but also to link patients to a community prescriber who will continue the medication after discharge. Buprenorphine can control the cravings to use drugs that are triggered by the stressors of returning to the real world after rehab. Moreover, while sequestered at rehab, people lose their tolerance to opioids. With their bodies no longer accustomed to using the amount of street drugs that they used before, they are especially vulnerable to a fatal overdose—which can be prevented with buprenorphine. How Can People With OUD Access Buprenorphine Treatment? If a patient with OUD is safe in their current home environment, they can start buprenorphine while remaining in the community. You can find outpatient buprenorphine prescribers here. If you or your loved one is seeking inpatient or residential treatment for OUD, inquire about each facility’s policy on buprenorphine. This means asking not only whether they provide short-term buprenorphine for withdrawal management (or “detox”) but also whether they support long-term use, including providing a bridge prescription to last until patients establish with an outpatient prescriber. By asserting a right to evidence-based treatment, patients and their loved ones can erode the stigma against medications that has clung to the addiction treatment world for far too long.
    0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
Páginas Impulsionadas
Patrocinado
google-site-verification: google037b30823fc02426.html
Patrocinado
google-site-verification: google037b30823fc02426.html